Experience with glycoprotein IIb/IIIa antagonists in patients with acute coronary syndromes.
Kandzari
David E
DE
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA. kandz002@onyx.dcri.duke.edu
Mahaffey
Kenneth W
KW
D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary; D013504:Cardiovascular Surgical Procedures / Q000379:methods; D002986:Clinical Trials as Topic; D003328:Coronary Thrombosis / Q000517:prevention & control; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex